These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 14827945

  • 1. Clinical experiences with the anticoagulant, ethyl biscoumacetate (N.N.R.).
    BARKER NW, ESTES JE, MANN FD.
    Proc Staff Meet Mayo Clin; 1951 Apr 25; 26(9):162-7. PubMed ID: 14827945
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic value of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C, SIGUIER F, WELTI JJ, COBLENTZ B, NEDEY, BREYNAERT.
    Sem Hop; 1951 May 10; 27(35):1511-22. PubMed ID: 14866256
    [No Abstract] [Full Text] [Related]

  • 3. [Pharmacological properties and physiological effects of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C, SIGUIER F, WELTI JJ, PIETTE M, POULLAIN P, PHILIPPON J.
    Sem Hop; 1951 May 10; 27(35):1505-11. PubMed ID: 14866255
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A new synthetic anticoagulant, the ethyl ester of dioxycoumarinyl-acetic acid or tromexan].
    BICKEL G, DELLA SANTA R.
    Rev Med Suisse Romande; 1949 Sep 25; 69(9):545-58. PubMed ID: 18140885
    [No Abstract] [Full Text] [Related]

  • 6. Clinical evaluation of dicumarinyl derivatives with a metabolic study of the radioactively labeled anticoagulants in animals.
    HAUSNER EP, SHAFER CL, CORSON M, JOHNSON O, TRUJILLO T, LANGHAM W.
    Circulation; 1951 Feb 25; 3(2):171-81. PubMed ID: 14812645
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T.
    Acta Med Scand; 1956 Sep 06; 155(3):161-70. PubMed ID: 13361829
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical results with tromexan, a new anticoagulant].
    von KAULLA KN.
    Dtsch Med Wochenschr; 1950 Sep 22; 75(38):1259-62. PubMed ID: 14773354
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical trials with a new anticoagulant; tromexan].
    MILANES B, HERNANDEZ A, PEREZ STABLE E.
    Rev Cubana Cardiol; 1951 Sep 22; 12(4):141-50. PubMed ID: 12994207
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A study on the toxicology and anticoagulant action of tromexan, a synthetic coumarin.
    GRUBER CM, LEE KS, LASZICZENKO T, GRUBER CM.
    Arch Int Pharmacodyn Ther; 1951 Sep 01; 87(4):402-12. PubMed ID: 14895202
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A new anticoagulant, tromexan; its action in health and disease and the interference of other medicinals].
    AVELLANEDA M, CASTRO CM, STRITZLER G.
    Cardiologia (Basel); 1953 Sep 01; 22(6):321-32. PubMed ID: 13082497
    [No Abstract] [Full Text] [Related]

  • 18. The coagulation defect caused by tromexan therapy.
    DOUGLAS AS.
    Clin Sci; 1955 Nov 01; 14(4):601-13. PubMed ID: 13270444
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [CHYMORAL AND COAGULATION].
    PESSEREAU G, MONTEIL R.
    Rev Int Serv Sante Armees; 1963 Nov 01; 36():647-59. PubMed ID: 14094765
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.